Transdiagnostic Use of 3,4-methylenedioxymethamphetamine-assisted Therapy to Treat Obsessive-compulsive Disorder
Overview
Overview
Journal
Br J Psychiatry
Publisher
Cambridge University Press
Specialty
Psychiatry
Date
2025 Feb 26
PMID
40001303
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
This article explores the potential of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy to enhance exposure and response prevention in obsessive-compulsive disorder treatment. We discuss the mechanisms of MDMA, including fear extinction, psychological flexibility, and empathogenic effects that may improve adherence and efficacy, as well as highlighting important safety considerations for further research.